At the end of the CPE activity the pharmacist (P) and pharmacy technicians (PT) will be able to:

• Describe key developments in AI, its current investment landscape, and its potential impact on various business sectors, particularly healthcare and pharmaceuticals.
• Describe the difference between the current capabilities of electronic prior-authorizations platforms and the ones that use artificial intelligence.
• Discuss how disease management tools using artificial intelligence may contribute to improve economic and utilization outcomes of medication management.
• Describe how AI can be applied to improve various aspects of the patient journey, including initial training, medication adherence, and outcomes tracking.
• Recognize strategies for integrating AI tools into clinical workflows to improve outcomes and reduce costs.